US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sionna Therapeutics

11.07

+1.0710.70%

Post-market: 11.070.00000.00%16:00 EDT

Volume:186.21K

Turnover:2.04M

Market Cap:488.46M

PE:-0.69

High:11.51

Open:9.68

Low:9.39

Close:10.00

Loading ...

Overview Company News Filings

TD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY

Sionna Therapeutics - Qtrly Loss per Share $3.38

THOMSON REUTERS

Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS

Sionna Therapeutics initiated with a Buy at TD Cowen

Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target

MT Newswires Live

Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target

MT Newswires Live

TD Cowen Initiates Sionna Therapeutics at Buy

MT Newswires Live

Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS

Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation

Sionna Therapeutics initiated with a Buy at Guggenheim

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market

Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10

Atlas Venture Fund Xi L.p Reports 6.5% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing

THOMSON REUTERS

Andreas Halvorsen's Strategic Acquisition in Sionna Therapeutics Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SION/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":11.07,"timestamp":1744920000000,"preClose":10,"halted":0,"volume":186207,"hourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"delay":0,"floatShares":15943083,"shares":44124394,"eps":-15.986072,"marketStatus":"Market Closed","change":1.07,"latestTime":"04-17 16:00:00 EDT","open":9.68,"high":11.51,"low":9.39,"amount":2040956.7276,"amplitude":0.212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.986072,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":10,"preHourTrading":{"tag":"盘前","latestPrice":9.67,"preClose":10,"latestTime":"07:02 EDT","volume":538,"amount":4936.619674,"timestamp":1744887734606},"postHourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"volumeRatio":1.3690140965305357},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":15943083,"roa":"-37.10%","roe":"-61.44%","lyrEps":-15.986072,"volumeRatio":1.3690140965305357,"shares":44124394,"dividePrice":0,"high":11.51,"amplitude":0.212,"preClose":10,"low":9.39,"week52Low":7.255,"pbRate":"-2.98","week52High":25.19,"institutionHeld":0,"latestPrice":11.07,"eps":-15.986072,"divideRate":0,"volume":186207,"delay":0,"ttmEps":-15.986072,"open":9.68,"prevYearClose":18,"prevWeekClose":7.87,"prevMonthClose":10.46,"prevQuarterClose":10.46,"fiveDayClose":7.66,"twentyDayClose":13.88,"sixtyDayClose":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521255434","title":"TD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521255434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521255434?lang=en_us&edition=fundamental","pubTime":"2025-03-22 02:55","pubTimestamp":1742583350,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. (SION – Research Report) today. The company’s shares opened today ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","COWN","TD"],"gpt_icon":0},{"id":"2520043069","title":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520043069","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520043069?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:18","pubTimestamp":1742469488,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44413626/sionna-therapeutics-q4-eps-3-38-up-from-3-93-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2520374454","title":"Sionna Therapeutics - Qtrly Loss per Share $3.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2520374454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520374454?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA9HJBBJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2520437381","title":"Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437381?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline data anticipated in first half of 2025. On track to initiate NBD1 Phase 2a proof-of-concept trial in combination with SOC in CF patients and combination MAD trials of an NBD1 stabilizer with a complementary modulator in healthy volunteers in the second half of 2025, with topline data for both anticipated in mid-2026. Completed upsized IPO with gross proceeds of approximately $219 million, extending runway into 2028","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4181","BK4218","SION","BK4585","CF","BK4093","BK4139","BK4213","PK","SOC"],"gpt_icon":0},{"id":"2519346994","title":"Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2519346994","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519346994?lang=en_us&edition=fundamental","pubTime":"2025-03-16 04:43","pubTimestamp":1742071388,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other top insider purchases last month.How will new tariffs impact the U.S. economy?What’s next on President Trump’s geopolitical agenda?These are some of the concerning questions influencing market conditions.According to J.P. Morgan’s chief global economist, Bruce Kasman, there is about a 40% chance of a U.S. recession and a risk of lasting damage to the country’s reputation as an investment destination, writes Reuters.“Where we stand now is with a heightened concern about the U.S. economy,” Kasman said to reporters in Singapore on Wednesday.Additionally, Goldman Sachs lowered its 2025-end target for the broader market. “The proximate causes of the market decline are the jump in policy uncertainty largely related to tariffs, concerns about the economic growth outlook, and a positioning unwind, especially among hedge funds","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-204308018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2237443978.SGD","LU2471134523.USD","LU2750360997.AUD","LU2237443465.HKD","CF","LU2471134796.USD","LU0096364046.USD","BK4552","LU1868837136.USD","IE00B19Z3581.USD","LU2237443549.SGD","LU2750360641.GBP","BK4533","BK4588","IE0004091025.USD","LU0106831901.USD","LU2471134879.HKD","LU2237443622.USD","LU2237443895.HKD","BK4504","LU1868836914.USD","LU1868837300.USD","SION","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE0034235188.USD","BK4093","BK4585","LU1868836757.USD","BK4127","BK4516","IE0002270589.USD","LU0061475181.USD","IE0004086264.USD","IE00BFXG1179.USD","LU1868836591.USD","LU2237443382.USD","LU1668664300.SGD","LU2237438978.USD","LU1791807156.HKD","LU2471134952.CNY","BK4550"],"gpt_icon":0},{"id":"2517961079","title":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517961079?lang=en_us&edition=fundamental","pubTime":"2025-03-05 15:53","pubTimestamp":1741161195,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott InternationalMarch 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO0SE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4114","BK4539","MAR","BK4139","CHH","BK4121","LU2463526074.USD","YUM","AZO","BK4560","CHPT","WH","H","LU0965509010.AUD","LU2238339852.HKD","MGA","SNDK","WDC","IE00B894F039.SGD","CRWD","LU2092937221.SGD","LU2360108059.USD","BOX","LU1934455194.USD","ROST","LU2362541513.USD","ACCD","TGT","LU2125910336.SGD","LU2229751404.USD","LU0240877869.USD","ACHC","LU2106854487.HKD","AKYA","LU0965508806.USD","LU2237443978.SGD","WM","RSG","SGRY","BK4185","LU1934455863.HKD","LU1720051017.SGD","BBY","HLT","SION","INGM","LU0106261612.USD","LU0211328371.USD","LU0240878834.USD","PASG"],"gpt_icon":1},{"id":"2517957069","title":"Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517957069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517957069?lang=en_us&edition=fundamental","pubTime":"2025-03-05 13:59","pubTimestamp":1741154363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO093:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2516367153","title":"Sionna Therapeutics initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516367153?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:36","pubTimestamp":1741095415,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of Sionna Therapeutics (SION) with a Buy rating. Sionna’s pipeline of cystic fibrosis therapies directly target NBD1, w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SION","TD","BK4139","BK4566","BK4207","COWN","BK4127"],"gpt_icon":0},{"id":"2516991673","title":"Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2516991673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516991673?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:36","pubTimestamp":1741091762,"startTime":"0","endTime":"0","summary":"Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2516529673","title":"Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2516529673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516529673?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:32","pubTimestamp":1741091533,"startTime":"0","endTime":"0","summary":"Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","SION"],"gpt_icon":0},{"id":"2516735526","title":"TD Cowen Initiates Sionna Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2516735526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516735526?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091429,"startTime":"0","endTime":"0","summary":"TD Cowen Initiates Sionna Therapeutics at Buy","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","SION","BK4139","BK4127","COWN","BK4207","TD","BK4585"],"gpt_icon":0},{"id":"2516678739","title":"Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678739?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:28","pubTimestamp":1741091325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2516678805","title":"Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678805?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:55","pubTimestamp":1741089335,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are desig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443549.SGD","LU2237443465.HKD","LU1868837300.USD","IE00BFXG1179.USD","LU2750360641.GBP","BK4552","BK4127","LU2750360997.AUD","LU0096364046.USD","LU2471134796.USD","BK4139","IE0034235188.USD","IE0004086264.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4588","LU1668664300.SGD","LU2237443622.USD","LU2471134952.CNY","LU0106831901.USD","LU2237438978.USD","SSI","LU1868836591.USD","BK4533","LU1791807156.HKD","SION","LU2237443382.USD","BK4516","LU0061475181.USD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1868836757.USD","LU1868836914.USD","LU2237443978.SGD","BK4504","BK4550","LU2471134523.USD","LU1868837136.USD","LU2237443895.HKD","IE0004091025.USD","IE00BSNM7G36.USD","BK4585"],"gpt_icon":0},{"id":"2516264946","title":"Sionna Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2516264946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516264946?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:55","pubTimestamp":1741082142,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Sionna Therapeutics (SION) with a Buy rating and $45 price target The firm has a positive view of NBD1 stabilizati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2516623001","title":"Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2516623001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516623001?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:26","pubTimestamp":1741080389,"startTime":"0","endTime":"0","summary":"Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Paul Matteis has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0079474960.USD","BK4139","LU0234570918.USD","IE00B19Z9Z06.USD","LU2362541273.HKD","BK4567","IE00BFTCPJ56.SGD","LU2362540622.SGD","IE0009355771.USD","BK4532","LU0058720904.USD","SION","IE00B19Z3B42.SGD","LU0256863811.USD","LU2456880835.USD","IE0002270589.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU1093756168.USD","CF","BK4023","IE00B19Z3581.USD","BK4093","BK4533","LU0061475181.USD","LU0417517546.SGD","LU1559883803.SGD","VERX","LU1035775433.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU0889565916.HKD","LU1585245621.USD","IE00B2B36J28.USD","LU2417539215.USD","LU2237438978.USD","VTNR","BK4138","LU1815336091.USD","LU0566484027.USD","LU0823416689.USD","VRTX","LU0757428866.USD","LU0320765992.SGD","BK4588","LU2324357040.USD","LU2362541513.USD"],"gpt_icon":0},{"id":"2516462587","title":"Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516462587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516462587?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:26","pubTimestamp":1741080371,"startTime":"0","endTime":"0","summary":"Yatin Suneja, an analyst from Guggenheim, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Yatin Suneja has given his Buy rating...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2516651996","title":"Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651996","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651996?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:57","pubTimestamp":1741024667,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other stocks with at least $10 million in insider spending recently.Since Donald Trump took office, the stock market has experienced a roller coaster ride. Nonetheless, despite concerns about tariffs, job cuts, policy changes, and geopolitical uncertainties, the broader market has risen by 1.46% year-to-date. Furthermore, equity strategists in a Reuters poll project that the broader market will finish the year 9% higher than its current level.“Many analysts agree with this projection, arguing that the Trump administration’s policies won’t have long-term negative impacts on economic growth or inflation. Furthermore, Trump is often considered the most pro-stock market president in American history.Our research has shown that we can outperform the market by imitating the top stock picks of the best","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-175747124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","BK4588","TSYW.SI","USJW.SI","QID","NQmain","NVIW.SI","PSQ","TQQQ","QLD","BK4093",".IXIC","SION","CF","BK4139","SQQQ","BK4585","MNQmain"],"gpt_icon":1},{"id":"2512116891","title":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2512116891","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512116891?lang=en_us&edition=fundamental","pubTime":"2025-02-19 07:03","pubTimestamp":1739919816,"startTime":"0","endTime":"0","summary":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 Feb 18  - Sionna Therapeutics Inc SION.O:ATLAS VENTURE FUND XI L.P REPORTS 6.5% STAKE IN SIONNA THERAPEUTICS AS OF FEB 10 - SEC FILINGSource text: [ID:]Further company coverage: SION.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2512113493","title":"Atlas Venture Fund Xi L.p Reports 6.5% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512113493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512113493?lang=en_us&edition=fundamental","pubTime":"2025-02-19 06:33","pubTimestamp":1739918009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2512162940","title":"Andreas Halvorsen's Strategic Acquisition in Sionna Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162940","media":"GuruFocus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512162940?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:29","pubTimestamp":1739885357,"startTime":"0","endTime":"0","summary":"On February 10, 2025, Andreas Halvorsen (Trades, Portfolio), a prominent figure in the investment world, made a significant move by acquiring 2,952,754 shares of Sionna Therapeutics Inc (SION, Financi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2701996/andreas-halvorsens-strategic-acquisition-in-sionna-therapeutics-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU0106261372.USD","LU0795875169.SGD","BK4504","LU0158827948.USD","LU1548497426.USD","LU2271345857.HKD","LU0971096721.USD","BK4551","IE00BKVL7J92.USD","BK4585","LU1720051017.SGD","LU2133065610.SGD","BK4548","LU0098860793.USD","LU2028103732.USD","LU2089283258.USD","BK4093","BNTX","LU2357305700.SGD","LU1732800096.USD","BK4516","BK4535","BK4588","IE00BZ1G4Q59.USD","LU1363072403.SGD","LU2089284900.SGD","LU0795875086.SGD","LU0106831901.USD","LU1720051108.HKD","LU0267386448.USD","CF","LU0912757837.SGD","BK4534","LU2023251221.USD","BK4139","LU1668664300.SGD","LU1074936037.SGD","LU0320765646.SGD","LU0314104364.USD","LU0158827781.USD","BK4568","LU1989772840.SGD","BK4581","LU0006306889.USD","LU1162221912.USD","LU1989772923.USD","SION","BK4127","LU1732799900.SGD","LU2111349929.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2025-04-17","current":-7.152833,"percent":0.836735,"low":-18.418073,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"high":-5.47907,"avg":-10.891452,"sd":3.207127,"marketCap":441243940},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940}],"updateTime":1745129050634}}}